Citizens, Inc. (CIA) AI Stock Analysis
CIA AI stock analysis summary
AI ResearchCitizens, Inc. (CIA) is an Austin, Texas-based provider of life, home service, and health insurance products serving domestic and international policyholders. Over the trailing twelve months, the company generated $255.0M in revenue with a net profit margin of 4.5% and an operating margin of -0.9%. Its shares trade at a trailing price-to-earnings ratio of 15.6x following a 1-year price return of -40.7%.
- Market cap
- $174.2M
- Revenue (TTM)
- $255.0M
- P/E
- 15.6x fwd 17.7x
- 1Y return
- -40.7% S&P 500 16.8%
- Avg. target
- $5.25 52.6% vs last close
Bull case
- The sole analyst tracking the stock has a mean price target of $5.25, representing an implied upside of 52.6% from the last close of $3.44.
- In the latest quarter ending June 30, 2026, quarterly earnings grew 99.5% year-over-year.
- The company trades at a price-to-book ratio of 0.8x and a price-to-sales ratio of 0.7x, below the median of its US-listed Financial Services peers at 3.2x price-to-sales.
Bear case
- Over the past year, the stock produced a return of -40.7%, trailing the S&P 500 return of 16.8%.
- Operating margin over the trailing twelve months turned negative at -0.9%, down from 6.8% in FY2025.
- Analyst estimates project full-year EPS to fall 57.1% to $0.12 for the fiscal year ending December 31, 2026.
What Citizens does
Founded in 1969 and based in Austin, Texas, Citizens, Inc. operates primarily through its Life Insurance and Home Service Insurance segments. The Life Insurance segment issues ordinary whole life insurance and endowment policies denominated in U.S. dollars, primarily serving non-U.S. residents through independent marketing agencies and consultants. The Home Service Insurance segment provides final expense life insurance and property insurance policies tailored for middle- and lower-income households across Louisiana, Mississippi, and Arkansas, partnering with funeral homes and independent agents. Additionally, the company offers health insurance policies to provide a comprehensive portfolio of insurance solutions across its domestic and international markets.
Growth and profitability
Between FY2021 and FY2025, Citizens, Inc. grew revenue from $250.5M to $255.6M, representing a 5-year revenue CAGR of 1.4%. Net income contracted from $72.7M in FY2021 to $14.6M in FY2025, with net margin narrowing from 29.0% to 5.7% over the same period. Operating margin stood at 6.8% in FY2025, down from 12.2% in FY2021. For the trailing twelve months, revenue reached $255.0M with diluted EPS of $0.22 and an operating margin of -0.9%. In the latest quarter ending June 30, 2026, quarterly revenue fell 7.2% year-over-year, while quarterly earnings growth increased 99.5%.
Balance sheet and cash flow
As of June 30, 2026, Citizens, Inc. held $31.9M in cash and short-term investments, with total assets of $1.75B and shareholders' equity of $235.2M. In FY2025, operating cash flow was $18.0M and free cash flow was $17.5M, down from $31.9M and $31.3M, respectively, in FY2024. Capital allocation in FY2025 included capital expenditures of $447,000 and share buybacks of $278,000. Over a 5-year period, the company's share count changed by 2.9%.
Valuation and performance
At a last close of $3.44 on October 16, 2026, Citizens, Inc. has a market cap of $174.2M and an enterprise value of $163.4M. Its trailing P/E ratio of 15.6x and forward P/E of 17.7x stand above the median of its US-listed Financial Services peers, which report a trailing P/E of 12.1x and forward P/E of 10.8x. However, its price-to-sales ratio of 0.7x trades below the peer median of 3.2x, and its price-to-book ratio is 0.8x. Over the past year, the stock returned -40.7%, trailing the S&P 500 return of 16.8%.
What analysts expect
One analyst covers Citizens, Inc., assigning a Strong Buy rating. The mean price target of $5.25 reflects an upside of 52.6% over the last close of $3.44. For the fiscal year ending December 31, 2026, the analyst estimates EPS of $0.12, reflecting an EPS growth decline of 57.1%, alongside revenue of $256.2M. For the next fiscal year, the estimate calls for EPS of $0.20 on revenue of $267.1M. The company beat EPS estimates in 2 of the last 4 quarters, with its next earnings report scheduled for November 5, 2026.
Key risks and what to watch
- Revenue for the latest quarter ending June 30, 2026 declined 7.2% year-over-year.
- Free cash flow decreased from $31.3M in FY2024 to $17.5M in FY2025.
- Short interest represents 8.9% of the company's float, while the stock trades 30.2% below its 200-day moving average.
AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer
About this CIA AI stock analysis
This page is an AI-written research summary of Citizens, Inc. (CIA). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.
Related: CIA income statement, CIA balance sheet, CIA key metrics, CIA analyst forecast, CIA chart. See the CIA stock overview for the latest quote and news.
CIA AI stock analysis FAQ
Does Citizens, Inc. (CIA) pay a dividend?
Citizens, Inc. does not currently report an active dividend payout.
What is the analyst price target for Citizens, Inc. (CIA)?
The single analyst covering CIA has a mean price target of $5.25, which is 52.6% above its closing price of $3.44 on October 16, 2026.
How did Citizens, Inc. perform in its latest financial quarter?
For the quarter ended June 30, 2026, quarterly revenue fell 7.2% year-over-year, while quarterly earnings grew 99.5%.
What is Citizens, Inc.'s valuation relative to its industry peers?
Citizens, Inc. trades at a trailing P/E of 15.6x, compared to the median of 12.1x for its US-listed Financial Services peers, though its price-to-sales ratio of 0.7x is lower than the peer median of 3.2x.